CLINICAL_TRIALS trial_result · 2013-10-28

Clinical Trial Update: Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes [Phase 3]

A Phase 3 efficacy and safety study of MP-513 in combination with a thiazolidinedione in type 2 diabetes has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-10-28